Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Quxie Capsule Inhibits Colon Tumor Growth Partially Through Foxo1-Mediated Apoptosis and Immune Modulation - Dongmei Chen, Yufei Yang, Peiying Yang, 2019
A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models: Molecular Therapy - Oncolytics
New shuttle session with our in vivo syngeneic tumor models – for cost-saving efficacy studies - by Explicyte Immuno-Oncology
Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment | Scientific Reports
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer | Aging
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text
Tumor efficacy and biodistribution of Ad-Cab in syngeneic mouse model... | Download Scientific Diagram
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays
CT26 Xenograft Model | Xenograft Services
PD1 / PDL1 Blockade In Mouse Tumor Syngeneic Models - by Explicyte Immuno-Oncology
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text
CT26 Tumor Model | Melior Discovery
a Growth of Sa1N, CT26, ASB-XIV, or MC38 syngeneic tumors was measured... | Download Scientific Diagram
Advancing Immunotherapy Research: Syngeneic Tumor Models for Preclinical Success
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Induction of CD4+ and CD8+ anti‐tumor effector T cell responses by bacteria mediated tumor therapy - Stern - 2015 - International Journal of Cancer - Wiley Online Library
New In Vivo Syngeneic Subcutaneous CT26 Colon Tumor Model Shuttle Session - by Explicyte Immuno-Oncology
Antitumor Activities of Immune Costimulatory Molecules of TNF Superfamily in Colorectal and Lung Cancers
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer - Figure f1 | Aging
PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation | Journal for ImmunoTherapy of Cancer
Syngeneic Mouse Models, Syngeneic Tumor Models | Melior Discovery
sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... | Download Scientific Diagram
